Flexion Therapeutics, Inc. (FLXN) CEO Michael Clayman on Q2 2021 Results – Earnings Call Transcript
Flexion Therapeutics, Inc. (FLXN) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ET
Company Participants
Scott Young – Vice President, Corporate Communications and Investor Relations
Michael Clayman – Chief Executive Officer
Melissa Layman – Chief…
